Presse

Partenariat Cerba HealthCare et VitaDX pour la validation d’un test de diagnostic précoce du cancer de la vessie.

Paris, France, March 21, 2017. Cerba Healthcare S.A.S. and its affiliates (the “Cerba Group”) announced today that NewCo Sab MidCo S.A.S...

Conditional notice of redemption.

Paris, France, March 20, 2017. Cerba Healthcare S.A.S. and its affiliates (the “Cerba Group”) announced today that NewCo Sab MidCo S.A.S...

CERBA et IntegraGen signent un accord de licence pour la réalisation du test miR-31-3p en cancérologie.